Recent Finacing
Recent Raise
TAXIS Pharmaceuticals is a clinical-stage biotech developing efflux pump inhibitors and FtsZ-targeting drugs via its TAXISTANCE platform to restore activity of approved antibiotics against multidrug-resistant Gram-negative pathogens.
